Results 261 to 270 of about 96,342 (294)

Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment

Allergy. European Journal of Allergy and Clinical Immunology, 2021
The AMAZES randomized controlled trial demonstrated that long‐term low‐dose azithromycin treatment reduces exacerbations of poorly controlled asthma, but the therapeutic mechanisms remain unclear. Dysregulation of the inflammatory tumour necrosis factor (
Natalie M. Niessen, P. Gibson, K. Baines, Daniel Barker, I. Yang, J. Upham, P. Reynolds, S. Hodge, A. James, C. Jenkins, M. Peters, G. Marks, M. Baraket, J. Simpson, M. Fricker   +14 more
semanticscholar   +1 more source

Azithromycin

Reactions Weekly, 2015
  +7 more sources

Azithromycin

Reactions Weekly, 2022
  +4 more sources

Azithromycin

Reactions Weekly, 2023
openaire   +2 more sources

Azithromycin

Reactions Weekly, 2013
  +4 more sources

Azithromycin

Reactions Weekly, 2018
  +5 more sources

Azithromycin

Reactions Weekly
  +6 more sources

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet, The, 2021
Muhammad S Ahmed, Naseer Ahmed, Syed Ali
exaly  

Azithromycin

Reactions Weekly, 2016
openaire   +2 more sources

Azithromycin

Reactions Weekly, 2020
openaire   +1 more source